C4 Therapeutics, Inc. (CCCC)
3.10
+0.15
(+5.08%)
USD |
NASDAQ |
Nov 06, 16:00
3.09
-0.01
(-0.32%)
After-Hours: 20:00
C4 Therapeutics Total Assets (Quarterly) : 331.80M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 331.80M |
| June 30, 2026 | 359.40M |
| March 31, 2026 | 328.86M |
| December 31, 2025 | 371.94M |
| September 30, 2025 | 265.49M |
| June 30, 2025 | 296.53M |
| March 31, 2025 | 319.52M |
| December 31, 2024 | 349.60M |
| September 30, 2024 | 376.06M |
| June 30, 2024 | 381.09M |
| March 31, 2024 | 398.37M |
| December 31, 2023 | 376.45M |
| September 30, 2023 | 333.01M |
| June 30, 2023 | 375.01M |
| Date | Value |
|---|---|
| March 31, 2023 | 396.04M |
| December 31, 2022 | 430.84M |
| September 30, 2022 | 461.44M |
| June 30, 2022 | 492.48M |
| March 31, 2022 | 515.48M |
| December 31, 2021 | 506.76M |
| September 30, 2021 | 507.91M |
| June 30, 2021 | 528.42M |
| March 31, 2021 | 374.01M |
| December 31, 2020 | 400.14M |
| September 30, 2020 | 229.13M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 118.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 902.56M |
| Kymera Therapeutics, Inc. | 1.767B |
| NKGen Biotech, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 103.63M |
| Shareholders Equity (Quarterly) | 228.17M |
| Debt to Equity Ratio | 0.2421 |
| Current Ratio | 5.174 |
| Net Debt Paydown Yield | 0.35% |